<?xml version="1.0" encoding="gb2312" ?>
<?xml-stylesheet type="text/xsl" href="RSS_xslt_style.asp" version="1.0" ?>
<rss version="2.0" xmlns:WebWizForums="http://syndication.webwiz.co.uk/rss_namespace/">
 <channel>
  <title>ADHD互助社区 : GREAT NEWS！FDA批准一种干预ADHD症状的便携设备</title>
  <link>http://www.adhd.org.cn/forum/</link>
  <description><![CDATA[此系XML聚合内容，来自; ADHD互助社区 : 其它方法 : GREAT NEWS！FDA批准一种干预ADHD症状的便携设备]]></description>
  <copyright>Copyright (c) 2006-2013 ADD Forums - All Rights Reserved.</copyright>
  <pubDate>Mon, 04 May 2026 15:27:33 +0000</pubDate>
  <lastBuildDate>Mon, 09 Dec 2019 17:22:18 +0000</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <generator>ADD Forums 10.16</generator>
  <ttl>360</ttl>
  <WebWizForums:feedURL>www.adhd.org.cn/forum/RSS_post_feed.asp?TID=14197</WebWizForums:feedURL>
  <image>
   <title><![CDATA[ADHD互助社区]]></title>
   <url>http://www.adhd.org.cn/forum/forum_images/web_wiz_forums.png</url>
   <link>http://www.adhd.org.cn/forum/</link>
  </image>
  <item>
   <title><![CDATA[GREAT NEWS！FDA批准一种干预ADHD症状的便携设备 : 这个现在怎么样？有进展么？大概是基于什么原理？ ]]></title>
   <link>http://www.adhd.org.cn/forum/forum_posts.asp?TID=14197&amp;PID=41966&amp;title=great-newsfdaadhd#41966</link>
   <description>
    <![CDATA[<strong>发表人:</strong> <a href="http://www.adhd.org.cn/forum/member_profile.asp?PF=11387">dearbird</a><br /><strong>标题:</strong> 14197<br /><strong>发表:&nbsp;</strong> 2019/12/09  5:22pm<br /><br />这个现在怎么样？有进展么？大概是基于什么原理？<div><br></div>]]>
   </description>
   <pubDate>Mon, 09 Dec 2019 17:22:18 +0000</pubDate>
   <guid isPermaLink="true">http://www.adhd.org.cn/forum/forum_posts.asp?TID=14197&amp;PID=41966&amp;title=great-newsfdaadhd#41966</guid>
  </item> 
  <item>
   <title><![CDATA[GREAT NEWS！FDA批准一种干预ADHD症状的便携设备 : http://www.neurosigma.com/tns/adhd.htmlExploring...]]></title>
   <link>http://www.adhd.org.cn/forum/forum_posts.asp?TID=14197&amp;PID=41530&amp;title=great-newsfdaadhd#41530</link>
   <description>
    <![CDATA[<strong>发表人:</strong> <a href="http://www.adhd.org.cn/forum/member_profile.asp?PF=10437">EEEric</a><br /><strong>标题:</strong> 14197<br /><strong>发表:&nbsp;</strong> 2019/4/26  8:59am<br /><br /><h1 style="border-bottom-color: currentColor; border-bottom-style: n&#111;ne; border-bottom-width: medium; border--outset: 0; border--repeat: stretch; border--slice: 100%; border--source: n&#111;ne; border--width: 1; border-left-color: currentColor; border-left-style: n&#111;ne; border-left-width: medium; border-right-color: currentColor; border-right-style: n&#111;ne; border-right-width: medium; border-top-color: currentColor; border-top-style: n&#111;ne; border-top-width: medium; color: rgb0, 82, 155; font-family: &amp;quot;freight-sans-pro&amp;quot;,sans-serif; font-size: 2.28em; font-style: normal; font-variant: normal; font-weight: 600; letter-spacing: normal; line-height: 1em; margin-bottom: 30px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; text-decorati&#111;n: n&#111;ne; text-indent: 0px; text-trans: n&#111;ne; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">http://www.neurosigma.com/tns/adhd.html<br></h1><h1 style="border-bottom-color: currentColor; border-bottom-style: n&#111;ne; border-bottom-width: medium; border--outset: 0; border--repeat: stretch; border--slice: 100%; border--source: n&#111;ne; border--width: 1; border-left-color: currentColor; border-left-style: n&#111;ne; border-left-width: medium; border-right-color: currentColor; border-right-style: n&#111;ne; border-right-width: medium; border-top-color: currentColor; border-top-style: n&#111;ne; border-top-width: medium; color: rgb0, 82, 155; font-family: &amp;quot;freight-sans-pro&amp;quot;,sans-serif; font-size: 2.28em; font-style: normal; font-variant: normal; font-weight: 600; letter-spacing: normal; line-height: 1em; margin-bottom: 30px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; text-decorati&#111;n: n&#111;ne; text-indent: 0px; text-trans: n&#111;ne; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;"><br></h1><h1 style="border-bottom-color: currentColor; border-bottom-style: n&#111;ne; border-bottom-width: medium; border--outset: 0; border--repeat: stretch; border--slice: 100%; border--source: n&#111;ne; border--width: 1; border-left-color: currentColor; border-left-style: n&#111;ne; border-left-width: medium; border-right-color: currentColor; border-right-style: n&#111;ne; border-right-width: medium; border-top-color: currentColor; border-top-style: n&#111;ne; border-top-width: medium; color: rgb0, 82, 155; font-family: &amp;quot;freight-sans-pro&amp;quot;,sans-serif; font-size: 2.28em; font-style: normal; font-variant: normal; font-weight: 600; letter-spacing: normal; line-height: 1em; margin-bottom: 30px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; text-decorati&#111;n: n&#111;ne; text-indent: 0px; text-trans: n&#111;ne; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">Exploring Innovative Therapies</h1><span style="display: inline !imant; : n&#111;ne; : rgb255, 255, 255; color: rgb66, 66, 66; font-family: Arial,Helvetica,sans-serif; font-size: 13.93px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decorati&#111;n: n&#111;ne; text-indent: 0px; text-trans: n&#111;ne; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">						</span><p style="border-bottom-color: currentColor; border-bottom-style: n&#111;ne; border-bottom-width: medium; border--outset: 0; border--repeat: stretch; border--slice: 100%; border--source: n&#111;ne; border--width: 1; border-left-color: currentColor; border-left-style: n&#111;ne; border-left-width: medium; border-right-color: currentColor; border-right-style: n&#111;ne; border-right-width: medium; border-top-color: currentColor; border-top-style: n&#111;ne; border-top-width: medium; color: rgb68, 68, 68; font-family: &amp;quot;freight-sans-pro&amp;quot;,arial,sans-serif; font-size: 1.42em; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 1.66em; margin-bottom: 35px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; text-decorati&#111;n: n&#111;ne; text-indent: 0px; text-trans: n&#111;ne; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;" ="intro"="">NeuroSigma, Inc. is developing trigeminal nerve stimulation (TNS) for a variety of disorders, including epilepsy, depression, attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD) Lennox-Gastaut syndrome (LGS) and traumatic brain injury (TBI). NeuroSigma’s unique TNS technology can be delivered via the non-invasive Monarch external trigeminal nerve stimulation (eTNS&#8482;) system or the minimally-invasive subcutaneous trigeminal nerve stimulation (sTNS&#8482;) system which is currently under development.</p><p style="border-bottom-color: currentColor; border-bottom-style: n&#111;ne; border-bottom-width: medium; border--outset: 0; border--repeat: stretch; border--slice: 100%; border--source: n&#111;ne; border--width: 1; border-left-color: currentColor; border-left-style: n&#111;ne; border-left-width: medium; border-right-color: currentColor; border-right-style: n&#111;ne; border-right-width: medium; border-top-color: currentColor; border-top-style: n&#111;ne; border-top-width: medium; color: rgb68, 68, 68; font-family: &amp;quot;freight-sans-pro&amp;quot;,arial,sans-serif; font-size: 1.42em; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 1.66em; margin-bottom: 35px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; text-decorati&#111;n: n&#111;ne; text-indent: 0px; text-trans: n&#111;ne; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;" ="intro"=""><br></p><p style="border-bottom-color: currentColor; border-bottom-style: n&#111;ne; border-bottom-width: medium; border--outset: 0; border--repeat: stretch; border--slice: 100%; border--source: n&#111;ne; border--width: 1; border-left-color: currentColor; border-left-style: n&#111;ne; border-left-width: medium; border-right-color: currentColor; border-right-style: n&#111;ne; border-right-width: medium; border-top-color: currentColor; border-top-style: n&#111;ne; border-top-width: medium; color: rgb68, 68, 68; font-family: &amp;quot;freight-sans-pro&amp;quot;,arial,sans-serif; font-size: 1.42em; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 1.66em; margin-bottom: 35px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; text-decorati&#111;n: n&#111;ne; text-indent: 0px; text-trans: n&#111;ne; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;" ="intro"=""><br></p><p style="border-bottom-color: currentColor; border-bottom-style: n&#111;ne; border-bottom-width: medium; border--outset: 0; border--repeat: stretch; border--slice: 100%; border--source: n&#111;ne; border--width: 1; border-left-color: currentColor; border-left-style: n&#111;ne; border-left-width: medium; border-right-color: currentColor; border-right-style: n&#111;ne; border-right-width: medium; border-top-color: currentColor; border-top-style: n&#111;ne; border-top-width: medium; color: rgb68, 68, 68; font-family: &amp;quot;freight-sans-pro&amp;quot;,arial,sans-serif; font-size: 1.42em; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 1.66em; margin-bottom: 35px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; text-decorati&#111;n: n&#111;ne; text-indent: 0px; text-trans: n&#111;ne; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;" ="intro"="">大意是用微电流刺激三叉神经，对ADHD PTSD等等症状有辅助治疗......</p><p style="border-bottom-color: currentColor; border-bottom-style: n&#111;ne; border-bottom-width: medium; border--outset: 0; border--repeat: stretch; border--slice: 100%; border--source: n&#111;ne; border--width: 1; border-left-color: currentColor; border-left-style: n&#111;ne; border-left-width: medium; border-right-color: currentColor; border-right-style: n&#111;ne; border-right-width: medium; border-top-color: currentColor; border-top-style: n&#111;ne; border-top-width: medium; color: rgb68, 68, 68; font-family: &amp;quot;freight-sans-pro&amp;quot;,arial,sans-serif; font-size: 1.42em; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 1.66em; margin-bottom: 35px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; text-decorati&#111;n: n&#111;ne; text-indent: 0px; text-trans: n&#111;ne; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;" ="intro"="">现在已经在米国，加拿大，欧盟，批准使用。不过应该是处方级别的。</p>]]>
   </description>
   <pubDate>Fri, 26 Apr 2019 08:59:11 +0000</pubDate>
   <guid isPermaLink="true">http://www.adhd.org.cn/forum/forum_posts.asp?TID=14197&amp;PID=41530&amp;title=great-newsfdaadhd#41530</guid>
  </item> 
 </channel>
</rss>